CDTX — Cidara Therapeutics Share News
0.000.00%
Last trade - 00:00- $6.95bn
- $6.53bn
- $1.28m
Brief: Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Coinbase, Rubrik, AeroVironment
U.S. STOCKS ON THE MOVE-Coinbase, Rubrik, AeroVironment
U.S. STOCKS ON THE MOVE-Array Technologies, Viking Therapeutics, Winnebago
U.S. STOCKS ON THE MOVE-Blackberry, Microsoft
Cidara Therapeutics falls after $350 mln equity offering priced
Brief: Cidara Prices Public Offering Of 7.95 Mln Shares At $44 Per Share
U.S. RESEARCH ROUNDUP- Amrize, Electronic Arts, PayPal
Cidara Therapeutics launches $250 mln equity offering after stock soars
Brief: Cidara Therapeutics To Commence $250 Million Public Offering
Brief: Cidara Therapeutics Announces Positive Topline Results From Its Phase 2B Navigate Trial
Cidara Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Cidara Therapeutics Inc Files For Mixed Shelf Of Up To $500 Million - SEC Filing
Cidara Therapeutics Inc expected to post a loss of $3.54 a share - Earnings Preview
Brief: Phathom Pharmaceuticals Appoints Ted Schroeder To Its Board Of Directors
Brief: Cidara Therapeutics Announces Appointment Of Frank Karbe As Chief Financial Officer
Brief: Cidara Therapeutics Completes Enrollment Of Phase 2b NAVIGATE Trial Evaluating CD388 for Prevention of Seasonal Influenza
U.S. STOCKS ON THE MOVE-Regions Financial, Red Cat, Summit Materials
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, SPAR, Alphabet